Clara Health
Total Raised
$10.59MInvestors Count
16Deal Terms
2Funding, Valuation & Revenue
10 Fundings
Clara Health has raised $10.59M over 10 rounds.
Clara Health's latest funding round was a Acquired for on March 9, 2022.
Clara Health's valuation in February 2018 was $10M.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
3/9/2022 | Acquired | 1 | ||||
1/17/2020 | Series A | $7.09M | Undisclosed Investors | 1 | ||
9/26/2019 | Incubator/Accelerator | 1 | ||||
2/20/2018 | Seed VC - III | $10M | ||||
6/16/2017 | Grant |
Date | 3/9/2022 | 1/17/2020 | 9/26/2019 | 2/20/2018 | 6/16/2017 |
|---|---|---|---|---|---|
Round | Acquired | Series A | Incubator/Accelerator | Seed VC - III | Grant |
Amount | $7.09M | ||||
Investors | Undisclosed Investors | ||||
Valuation | $10M | ||||
Revenue | |||||
Sources | 1 | 1 | 1 |
Clara Health Deal Terms
2 Deal Terms
Clara Health's deal structure is available for 2 funding rounds, including their Seed VC - III from February 20, 2018.
Round | Seed VC - III | Pre-Seed |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Seed VC - III | |||||||||||||||
Pre-Seed |
Clara Health Investors
16 Investors
Clara Health has 16 investors. M&B Sciences invested in Clara Health's Acquired funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
3/9/2022 | 3/9/2022 | 1 Acquired | Corporation | California | ||
9/26/2019 | 9/26/2019 | 1 Incubator/Accelerator | Incubator/Accelerator | |||
12/15/2016 | 2/20/2018 | 2 Pre-Seed, Seed VC - III (2018) | Angel Investor (Individual) | United States | ||
Venture Capital | California | |||||
Venture Capital | California |
First funding | 3/9/2022 | 9/26/2019 | 12/15/2016 | ||
|---|---|---|---|---|---|
Last Funding | 3/9/2022 | 9/26/2019 | 2/20/2018 | ||
Investor | |||||
Rounds | 1 Acquired | 1 Incubator/Accelerator | 2 Pre-Seed, Seed VC - III (2018) | ||
Board Seats | |||||
Type | Corporation | Incubator/Accelerator | Angel Investor (Individual) | Venture Capital | Venture Capital |
Location | California | United States | California | California |
Compare Clara Health to Competitors
Science 37 operates within the life sciences sector, providing solutions for patient access to clinical trials. The company's services aim to assist life sciences companies in conducting clinical research through various methods. It was founded in 2014 and is based in Morrisville, North Carolina. In March 2024, Science 37 was acquired by eMed at a valuation of $38M.
Castor operates within the healthcare sector and provides a clinical trial platform designed for the design, deployment, patient engagement, data collection, and analysis of clinical trials. The platform is adaptable and can meet the requirements of different stakeholders in the clinical research process. It primarily serves the healthcare sector. The company was founded in 2012 and is based in Amsterdam, Netherlands.
Bloqcube provides clinical trial management and financial systems software for the life sciences sector. The company offers a B2B platform that aggregates data in real-time, enhances security against ransomware attacks, and facilitates resource management for small and midsize life-science companies. Bloqcube's solutions are aimed at the healthcare and clinical research sectors. It was founded in 2017 and is based in Piscataway, New Jersey.
Curebase is a company that provides an eClinical platform in the clinical research sector, offering tools such as electronic patient-reported outcomes (ePRO), electronic clinical outcome assessments (eCOA), electronic consent (eConsent), and electronic data capture (EDC) systems. The platform is designed for study launches, data collection, and participant engagement. It was founded in 2017 and is based in San Francisco, California.
Evinova focuses on digital health solutions within the life sciences sector. The company provides products intended to support the clinical development lifecycle, including the unified trial solution and drug development suite, which are used for remote patient monitoring, electronic clinical outcome assessments, and data management in clinical trials. Evinova serves the pharmaceutical, biotech, and contract research organization industries with its digital solutions. It was founded in 2023 and is based in Baar, Switzerland.
Evidation is a company that focuses on real-world health experiences and their implications within the life sciences sector. It offers a platform that collects continuous, multimodal data from individuals to inform model development, disease progression, treatment experience, and outcomes. Evidation serves the life sciences industry by providing data for research and evidence generation. It was founded in 2012 and is based in San Mateo, California.
Loading...